Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Metabolic Health

Metabolite Changes After Metabolic Surgery – Associations to Parameters Reflecting Glucose Homeostasis and Lipid Levels

S. Ahlin; C. Cefalo; I. Bondia-Pons; K. Trošt; E. Capristo; L. Marini; M. Romero; A. Zorzano; A. Gastaldelli; G. Mingrone; J. J. Nolan Metabolite Changes After Metabolic Surgery – Associations to Parameters Reflecting Glucose Homeostasis and Lipid Levels Frontiers in Endocrinology

The E3 ubiquitin ligase Pellino3 protects against obesity-induced inflammation and insulin resistance

S. Yang; B. Wang; F. Humphries; A. E. Hogan; D. O'Shea; P. N. Moynagh The E3 ubiquitin ligase Pellino3 protects against obesity-induced inflammation and insulin resistance Immunity
Insulin Resistance & Diabetes

Lactobacillus reuteri FYNLJ109L1 Attenuating Metabolic Syndrome in Mice via Gut Microbiota Modulation and Alleviating Inflammation

B. Yang; F. Zheng; C. Stanton; R. P. Ross; J. Zhao; H. Zhang; W. Chen Lactobacillus reuteri FYNLJ109L1 Attenuating Metabolic Syndrome in Mice via Gut Microbiota Modulation and Alleviating Inflammation Foods
Metabolic Syndrome

Innate PD-L1 limits T cell-mediated adipose tissue inflammation and ameliorates diet-induced obesity

C. Schwartz; V. Schmidt; A. Deinzer; H. C. Hawerkamp; E. Hams; J. Bayerlein; O. Röger; M. Bailer; C. Krautz; A. El Gendy; M. Elshafei; H. M. Heneghan; A. E. Hogan; D. O'Shea; P. G. Fallon Innate PD-L1 limits T cell-mediated adipose tissue inflammation and ameliorates diet-induced obesity Sci Transl Med

I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice

D. K. Srinivasan; O. O. Ojo; B. O. Owolabi; J. M. Conlon; P. R. Flatt; Y. H. Abdel-Wahab I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice Acta Diabetol
Insulin Resistance & Diabetes

Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents

P. M. Ryan; E. Patterson; R. M. Kent; H. Stack; P. M. O'Connor; K. Murphy; V. L. Peterson; R. Mandal; D. S. Wishart; T. G. Dinan; J. F. Cryan; R. J. Seeley; C. Stanton; R. P. Ross Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents Sci Rep
Cholesterol

Arterio-venous metabolomics exploration reveals major changes across liver and intestine in the obese Yucatan minipig

N. Poupin; M. Tremblay-Franco; A. Amiel; C. Canlet; D. Rémond; L. Debrauwer; D. Dardevet; I. Thiele; M. K. Aurich; F. Jourdan; I. Savary-Auzeloux; S. Polakof Arterio-venous metabolomics exploration reveals major changes across liver and intestine in the obese Yucatan minipig Sci Rep
Insulin Resistance & Diabetes

NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity

C. Pellegrini; M. Fornai; L. Benvenuti; R. Colucci; V. Caputi; P. Palazon-Riquelme; M. C. Giron; A. Nericcio; F. Garelli; V. D'Antongiovanni; C. Segnani; C. Ippolito; M. Nannipieri; G. Lopez-Castejon; P. Pelegrin; G. Haskó; N. Bernardini; C. Blandizzi; L. NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity Br J Pharmacol

Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice

N. M. Pathak; P. J. B. Millar; V. Pathak; P. R. Flatt; V. A. Gault Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice Mol Cell Endocrinol
Cholesterol Insulin Resistance & Diabetes

Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice

V. Pathak; V. A. Gault; P. R. Flatt; N. Irwin Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice Mol Cell Endocrinol
Appetite & Satiety Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page48 Page49 Page50 … Page53 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI